Exploration of the clinical benefits of sodium glucose co-transporter 2 inhibitors in diabetic patients with concomitant heart failure
Crossref DOI link: https://doi.org/10.1186/s12933-018-0719-7
Published Online: 2018-05-25
Published Print: 2018-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Tanaka, Atsushi http://orcid.org/0000-0003-3352-7661
Node, Koichi
Text and Data Mining valid from 2018-05-25
Article History
Received: 15 May 2018
Accepted: 19 May 2018
First Online: 25 May 2018